Detection of small RNAS

• US 20060003337A1
• Filed: 06/30/2004
• Published: 01/05/2006
• Est. Priority Date: 06/30/2004
• Status: Abandoned Application

• Current Assignee: Applied Biosystems LLC (Thermo Fisher Scientific Incorporated)
• Original Assignee: Applied Biosystems LLC (Thermo Fisher Scientific Incorporated)
• Inventors: Bolchakova, Elena V., Karger, Achim E., Brandis, John
• Application Number:
  US10/881,362
• Publication Number:
  US 20060003337A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12Q 1/6844 Nucleic acid amplification reactions
• CPC Class Codes: C12Q 2561/101 Taqman
• CPC Class Codes: C12Q 2561/125 Ligase Detection Reaction [LDR]
• CPC Class Codes: C12Q 2565/1015 labels being on the same oligonucleotide

Abstract

Methods for detecting an RNA such as a small RNA comprising up to about 40 nucleotides are disclosed. The methods comprise forming a ligation mixture comprising a sample suspected of comprising the small RNA, a ligase and a target probe set. The target probe set comprises a first target probe comprising a 3′ portion that hybridizes to the small RNA and a 5′ portion having a first PCR primer target sequence, and a second target probe comprising a 5′ portion that hybridizes to the RNA immediately adjacent to the 3′ end of the first target probe and a 3′ portion having a second PCR primer target sequence. The target probe set hybridizes to the RNA and ligates to form a probe set ligation sequence. A probe set ligation sequence can be amplified and detected using a polymerase chain reaction.

Claims

1. A method for detecting a small RNA, the method comprising:

(1) forming a mixture comprising (a) a sample suspected of comprising the small RNA;

(b) a ligating agent; and

(c) a target probe set for detecting the small RNA, the target probe set comprising (i) a first target probe comprising a 3′

portion that hybridizes to the small RNA and a 5′

portion having a first PCR primer target sequence, and (ii) a second target probe comprising a 5′

portion that hybridizes to the RNA immediately adjacent to the 3′

end of the first target probe and a 3′

portion having a second PCR primer target sequence, wherein the mixture is formed under conditions in which a target probe set hybridizes to the RNA and ligates to form a probe set ligation sequence;

(2) forming a detection mixture comprising a probe set ligation sequence, a first PCR primer which hybridizes to the complement of the first PCR primer target, and a second PCR primer which hybridizes to the second PCR primer target;

(3) amplifying any probe set ligation sequence comprised by the detection mixture using a polymerase chain reaction; and

(4) detecting amplification of any probe set ligation sequence comprised by the detection mixture,

wherein the small RNA comprises a sequence consisting of from about 20 to about 40 contiguous nucleotides.

2. A method according to claim 1, wherein the small RNA comprises from about 20 to about 30 contiguous nucleotides.

3. A method according to claim 1, wherein the small RNA is an mRNA, an siRNA, or an snRNA.

4. A method according to claim 3, wherein the small RNA is selected from the group consisting of let-7a, miR-16, miR-20, and miR-30.

5. A method according to claim 1, wherein the 3′

portion of the first target probe that hybridizes to the small RNA and the 5′

portion of the second target probe that hybridizes to the small RNA together have a total of not more than about 40 nucleotides.

6. A method according to claim 5, wherein the 3′

portion of the first target probe that hybridizes to the small RNA and the 5′

portion of the second target probe that hybridizes to the small RNA together have a total of not more than about 25 nucleotides.

7. A method according to claim 1, wherein at least one target probe further comprises a detection probe hybridization sequence, and wherein the detection mixture further comprises a detection probe comprising a sequence that hybridizes to the detection probe hybridization sequence and a fluorophore, and wherein the detecting is by a fluorescence assay.

8. A method according to claim 7, wherein the 5′

nuclease detection assay is a real-time PCR assay.

9. A method according to claim 7, wherein the 5′

nuclease detection assay is an end-point PCR assay.

10. A method according to claim 7, wherein the fluorophore is selected from the group consisting of FAM, VIC, Sybra Green, TET, HEX, JOE, NED, LIZ, TAMRA, ROX, ALEXA, Texas Red, Cy3, Cy5, Cy7, Cy9, and dR6G.

11. A method according to claim 1, wherein at least one target probe further comprises a detection probe hybridization sequence, and at least one PCR primer comprises a label, and wherein the detecting comprises (i) contacting the detection mixture with an array comprising a plurality of detection loci in which each detection locus comprises a detection probe that hybridizes to the detection probe hybridization sequence, and (ii) detecting the label at a locus.

12. A method according to claim 11, wherein the label is a fluorophore selected from the group consisting of FAM, VIC, Sybra Green, TET, HEX, JOE, NED, LIZ, TAMRA, ROX, ALEXA, Texas Red, Cy3, Cy5, Cy7, Cy9, and dR6G.

13. A method according to claim 1, wherein at least one target probe further comprises a detection probe hybridization sequence, and wherein the detection mixture further comprises a detection probe comprising a sequence that hybridizes to the detection probe hybridization sequence, a label and an electrophoretic mobility modifier, and the detecting comprises detecting hybridization of the detection probe to the detection probe hybridization sequence by a gel electrophoresis assay.

14. A method according to claim 11, wherein the label is a fluorophore selected from the group consisting of FAM, VIC, Sybra Green, TET, HEX, JOE, NED, LIZ, TAMRA, ROX, ALEXA, Texas Red, Cy3, Cy5, Cy7, Cy9, and dR6G.

15. A method according to claim 1, wherein the ligating agent is a ligase.

16. A method according to claim 15, wherein the ligase is a T4 ligase.

17. A method according to claim 1, wherein the ligating agent is at least one of a chemical ligating agent comprising a phosphorothioate, a tosylate or iodide group.

18. A method according to claim 1, wherein the ligating agent is selected from the group consisting of carbodiimide, cyanogen bromide (BrCN), imidazole, 1-methylimidazole/carbodiimide/cystamine, N-cyanoimidazole, dithiothreitol (DTT) and ultraviolet light.

19. A method for detecting a small RNA in a sample, the method comprising:

(1) forming a mixture comprising (a) a sample suspected of comprising the small RNA;

(b) a target probe set for detecting the small RNA, the target probe set comprising (i) a first target probe comprising a 3′

portion that hybridizes to the small RNA and a 5′

portion having a first PCR primer target sequence, and (ii) a second target probe comprising a 5′

portion that hybridizes to the RNA immediately adjacent to the 3′

end of the first target probe and a 3′

portion having a second PCR primer target sequence, wherein one of the first or second target probes further comprises an affinity tag; and

(c) an affinity tag binding partner which is covalently attached to a solid phase support, wherein upon forming the mixture, a complex forms comprising the small RNA hybridized to the first target probe and the second target probe, and the affinity tag binding partner bound to the affinity tag;

(2) removing unhybridized first target probe and unhybridized second target probe from the mixture;

(3) forming a probe set ligation sequence by contacting the complex with a ligating agent;

(4) forming a detection mixture comprising the probe set ligation sequence, a first PCR primer which hybridizes to the complement of the first PCR primer target, and a second PCR primer which hybridizes to the second PCR primer target;

(5) amplifying any probe set ligation sequence; and

(6) detecting amplification of any probe set ligation sequence comprised by the mixture.

20. A method according to claim 19, wherein the method detects less than 1 attomole of the small RNA in the sample.

21. A method according to claim 19, wherein the method detects as few as 60,000 copies of the small RNA in the sample.

22. A method according to claim 19, wherein the method detects as few as 120,000 copies of the small RNA in the sample.

23. A method according to claim 19, wherein the affinity tag is selected from the group consisting of biotin and digoxygenin.

24. A method according to claim 19, wherein the affinity tag binding partner is selected from the group consisting of streptavidin, avidin, an antibody directed against biotin and an antibody directed against digoxygenin.

25. A method according to claim 19, wherein the solid phase support comprises a plurality of paramagnetic beads.

26. A method according to claim 19, wherein the small RNA comprises from about 20 to about 30 contiguous nucleotides.

27. A method according to claim 19, wherein the small RNA is a mRNA, a siRNA, or a snRNA.

28. A method according to claim 24, wherein the small RNA is selected from the group consisting of let-7a, miR-16, miR-20, and miR-30.

29. A method according to claim 19, wherein the 3′

portion of the first target probe that hybridizes to the small RNA and the 5′

portion of the second target probe that hybridizes to the small RNA together have a total of not more than about 40 nucleotides.

30. A method according to claim 19, wherein the 3′

portion of the first target probe that hybridizes to the small RNA and the 5′

portion of the second target probe that hybridizes to the small RNA together have a total of not more than about 25 nucleotides.

31. A method according to claim 19, wherein at least one target probe further comprises a detection probe hybridization sequence, and wherein the detection mixture further comprises a detection probe.

32. A method according to claim 28, wherein the detection probe is a 5′

-exonuclease assay probe

33. A method according to claim 31, wherein the detecting amplification comprises a real-time PCR assay.

34. A method according to claim 31, wherein the detecting amplification comprises an end-point PCR assay.

35. A method according to claim 19, wherein at least one target probe further comprises a detection probe hybridization sequence, and at least one PCR primer comprises a label, and wherein the detecting comprises (i) contacting the detection mixture with an array comprising a plurality of detection loci in which each detection locus comprises a detection probe that hybridizes to the detection probe hybridization sequence, and (ii) detecting the fluorophore at a locus.

36. A method for detecting small RNA according to claim 35, wherein the label is a fluorophore selected from the group consisting FAM, VIC, Sybra Green, TET, HEX, JOE, NED, LIZ, TAMRA, ROX, ALEXA, Texas Red, Cy3, Cy5, Cy7, Cy9, and dR6G.

37. A method according to claim 19, wherein at least one target probe further comprises a detection probe hybridization sequence, and wherein the detection mixture further comprises a detection probe comprising a sequence that hybridizes to the detection probe hybridization sequence, a label and an electrophoretic mobility modifier, and the detecting comprises detecting hybridization of the detection probe to the detection probe hybridization sequence by a gel electrophoresis assay.

38. A method according to claim 37, wherein the label is a fluorophore selected from the group consisting FAM, VIC, Sybra Green, TET, HEX, JOE, NED, LIZ, TAMRA, ROX, ALEXA, Texas Red, Cy3, Cy5, Cy7, Cy9, and dR6G.

39. A method according to claim 19, wherein the ligase is T4 ligase.

40. A small RNA detection kit comprising:

a first target probe comprising a 3′

portion that hybridizes to a small RNA and a 5′

portion having a first PCR primer target sequence;

a second target probe comprising a 5′

portion that hybridizes to the small RNA immediately adjacent to the 3′

portion of the first target probe and a 3′

portion having a second PCR primer target sequence, wherein upon hybridization of the first and second target probes to the small RNA in the presence of a ligase, a ligation sequence is formed, packaged in a container.

41. A kit according to claim 40, wherein one of the first or second target probes further comprises an affinity tag.

42. A kit according to claim 40, wherein the affinity tag is selected from the group consisting of biotin and digoxygenin.

43. A kit according to claim 40, further comprising an affinity tag binding partner attached to a solid phase support.

44. A kit according to claim 43, wherein the affinity tag binding partner is selected from the group consisting of streptavidin, avidin, an antibody directed against biotin and an antibody directed against digoxygenin.

45. A kit according to claim 43, wherein the solid phase support comprises a plurality of paramagnetic beads.

46. A kit according to claim 43, wherein the small RNA comprises from about 20 to about 30 contiguous nucleotides.

47. A kit according to claim 40, wherein the small RNA is a mRNA, a siRNA, or a snRNA.

48. A kit according to claim 47, wherein the small RNA is selected from the group consisting of let-7a, miR-16, miR-20, and miR-30.

49. A kit according to claim 40, wherein the 3′

portion of the first target probe that hybridizes to the small RNA and the 5′

portion of the second target probe that hybridizes to the small RNA together have a total of not more than about 40 nucleotides.

50. A kit according to claim 49, wherein the 3′

portion of the first target probe that hybridizes to the small RNA and the 5′

portion of the second target probe that hybridizes to the small RNA together have a total of not more than about 25 nucleotides.

51. A kit according to claim 40, wherein at least one target probe further comprises a detection probe hybridization sequence.

52. A kit according to claim 51, further comprising a detection probe which hybridizes to the detection probe hybridization sequence.

53. A kit according to claim 52, wherein the detection probe comprises a label.

54. A kit according to claim 53, wherein the label is a fluorophore selected from the group consisting of FAM, VIC, Sybra Green, TET, HEX, JOE, NED, LIZ, TAMRA, ROX, ALEXA, Texas Red, Cy3, Cy5, Cy7, Cy9, and dR6G.

55. A kit according to claim 54, wherein the detection probe further comprises a fluorescence quencher.

56. A kit according to claim 40, further comprising a ligase.

57. A kit according to claim 56, wherein the ligase is T4 ligase.

58. A kit according to claim 52, wherein the detection probe comprises an electrophoretic mobility modifier.

59. A kit according to claim 40, wherein the first and second target probes comprise a target probe set and the kit comprises a plurality of probe sets, wherein at least one target probe of each of the plurality of probe sets comprises a unique identifier sequence.

60. A kit according to claim 59, further comprising an array comprising a plurality of detection loci, wherein each detection locus comprises a hybridization probe that uniquely hybridizes to each unique identifier sequence.